PD Dr. Paul Gaß

Department of Obstetrics and Gynaecology Medizinische Fakultät

Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018) (2019) Schnürch HG, Ackermann S, Alt-Radtke CD, Angleitner L, Barinoff J, Beckmann M, Böing C, et al. Journal article Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer (2019) Fasching P, Gaß P, Häberle L, Volz B, Hein A, Hack C, Lux MP, et al. Journal article Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients (2019) Nabieva N, Häberle L, Brucker SY, Janni W, Volz B, Löhberg C, Hartkopf AD, et al. Journal article Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study (2019) Lux MP, Emons J, Bani M, Wunderle M, Sell C, Preuss C, Rauh C, et al. Journal article Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis (2019) Fasching P, Hartkopf AD, Gaß P, Häberle L, Akpolat-Basci L, Hein A, Volz B, et al. Journal article A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients (2018) Häberle L, Erber R, Gaß P, Hein A, Jud S, Langemann H, Rauh C, et al. Conference contribution Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients (2018) Hübner H, Fasching P, Gumbrecht W, Jud S, Rauh C, Matzas M, Paulicka P, et al. Journal article TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes (2018) Erber R, Hartmann A, Beckmann M, Mackensen A, Kremer A, Reimann H, Hübner H, et al. Journal article Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) Gaß P, Lux MP, Rauh C, Hein A, Bani M, Fießler C, Hartmann A, et al. Journal article The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer (2018) Brennan M, Gaß P, Häberle L, Wang D, Hartmann A, Lux MP, Beckmann M, et al. Journal article